The Polycomb group proteins bind throughout the INK4A-ARF locus and are disassociated in senescent cells

Adrian P Bracken1, Daniela Kleine-Kohlbrecher, Nikolaj Dietrich

  • 1Centre for Epigenetics, Biotech Research and Innovation Centre (BRIC), University of Copenhagen, Copenhagen 2200, Denmark. adrian.bracken@bric.dk

Genes & Development
|March 9, 2007
PubMed

Insights

The oncogene BMI1 represses cellular senescence regulators p16INK4A and p14ARF via Polycomb-Repressive Complex 2 (PRC2). Down-regulation of EZH2 in PRC2 activates transcription, providing a model for cancer development.

Area of Science:

  • Cellular biology
  • Molecular oncology
  • Epigenetics

Background:

  • The INK4A-ARF locus encodes p16INK4A and p14ARF proteins, crucial for cellular senescence.
  • Mechanisms controlling the upregulation of these senescence regulators are not fully understood.

Purpose of the Study:

  • To elucidate the mechanisms by which the oncogene BMI1 represses the INK4A-ARF locus.
  • To investigate the role of Polycomb-Repressive Complex 2 (PRC2) in regulating INK4A-ARF expression.

Main Methods:

  • Investigated the direct association between BMI1 and the INK4A-ARF locus.
  • Assessed the dependency of BMI1-mediated repression on the EZH2-containing PRC2 complex.
  • Monitored EZH2 levels, H3K27me3 marks, BMI1 displacement, and transcription in stressed and senescent cells.

Main Results:

  • BMI1's repression of the INK4A-ARF locus requires its direct association and the presence of PRC2.
  • EZH2 is downregulated in stressed and senescent cells.
  • Downregulation of EZH2 correlates with decreased H3K27me3, BMI1 displacement, and transcriptional activation of the INK4A-ARF locus.

Conclusions:

  • Established a model for INK4A-ARF locus activation.
  • Demonstrated how Polycomb proteins, specifically PRC2 and BMI1, contribute to cancer by regulating senescence pathways.

Related Concept Videos

Inheritance of Chromatin Structures03:17

Inheritance of Chromatin Structures

Epigenetics is the study of inherited changes in a cell's phenotype without changing the DNA sequences. It provides a form of memory for the differential gene expression pattern to maintain cell lineage, position-effect variegation, dosage compensation, and maintenance of chromatin structures such as telomeres and centromeres. For example, the structure and location of the centromere on chromosomes are epigenetically inherited. Its functionality is not dictated or ensured by the underlying DNA...
X-Inactivation01:58

X-Inactivation

The human X chromosome contains over ten times the number of genes as in the Y chromosome. Since males have only one X chromosome, and females have two, one might expect females to produce twice as many of the proteins, with undesirable results.
X-inactivation01:58

X-inactivation

The human X chromosome contains over ten times the number of genes as in the Y chromosome. Since males have only one X chromosome, and females have two, one might expect females to produce twice as many of the proteins, with undesirable results.
Eukaryotic Transcription Inhibitors01:52

Eukaryotic Transcription Inhibitors

Certain biochemical processes, such as embryonic development and cell growth regulation, depend on the repression of specific genes. DNA binding proteins known as eukaryotic transcription inhibitors regulate the repression of gene expression in eukaryotes. The presence of these inhibitors at the required location and time in the cell is triggered by the presence of hormones and additional signals from other cells.
Eukaryotic transcription inhibitors usually contain two distinct domains, a DNA...
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...